# Vivo Capital's Biotech Investments: 67 Startups in Its Portfolio (2026)

> The 67 Biotech startups Vivo Capital has backed, by stage: $11B raised between them. From the rounds we track; updated nightly.

Source: https://millionrounds.com/portfolio-maps/vivo-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article)

## Stage not reported

23

- [Candid Therapeutics](https://millionrounds.com/company/candid-therapeutics)
- [Legend Biotech](https://millionrounds.com/company/legend-biotech)
- [Immunic Therapeutics](https://millionrounds.com/company/immunic-therapeutics)
- [Valneva](https://millionrounds.com/company/valneva)
- [Biohaven Pharmaceutical](https://millionrounds.com/company/biohaven-pharmaceutical)
- [COMPASS Pathways](https://millionrounds.com/company/compass-pathways)
- [Tourmaline Bio](https://millionrounds.com/company/tourmaline-bio)
- [Celladon](https://millionrounds.com/company/celladon)
- [OnKure Therapeutics](https://millionrounds.com/company/onkure-therapeutics)
- [VectivBio](https://millionrounds.com/company/vectivbio)
- [Bonum Therapeutics](https://millionrounds.com/company/bonum-therapeutics)
- [Semnur Pharmaceuticals](https://millionrounds.com/company/semnur-pharmaceuticals)
- [Aligos Therapeutics](https://millionrounds.com/company/aligos-therapeutics)
- [SAB Biotherapeutics](https://millionrounds.com/company/sab-biotherapeutics)
- [AN2 Therapeutics](https://millionrounds.com/company/an2-therapeutics)
- [Pasithea Therapeutics](https://millionrounds.com/company/pasithea-therapeutics)
- [*I* Innocare](https://millionrounds.com/company/innocare)
- [Ossium Health](https://millionrounds.com/company/ossium-health)
- [Unicycive Therapeutics](https://millionrounds.com/company/unicycive-therapeutics)
- [Clene Nanomedicine](https://millionrounds.com/company/clene-nanomedicine)
- [IO Biotech](https://millionrounds.com/company/io-biotech)
- [Ocelot Bio](https://millionrounds.com/company/ocelot-bio)
- [Pulmobiotics](https://millionrounds.com/company/pulmobiotics)

## Series B

18

- [Terns Pharmaceuticals](https://millionrounds.com/company/terns-pharmaceuticals)
- [*CT* Cidara Therapeutics](https://millionrounds.com/company/cidara-therapeutics)
- [Passage Bio](https://millionrounds.com/company/passage-bio)
- [Expedition Therapeutics](https://millionrounds.com/company/expedition-therapeutics)
- [Surrozen](https://millionrounds.com/company/surrozen)
- [*BB* Bolt Biotherapeutics](https://millionrounds.com/company/bolt-biotherapeutics)
- [Gracell Biotechnologies](https://millionrounds.com/company/gracell-biotechnologies)
- [Homology Medicines](https://millionrounds.com/company/homology-medicines)
- [Avistone Pharmaceuticals](https://millionrounds.com/company/avistone-pharmaceuticals)
- [SonoThera](https://millionrounds.com/company/sonothera)
- [EpiBiologics](https://millionrounds.com/company/epibiologics)
- [NeuroGastrx](https://millionrounds.com/company/neurogastrx)
- [Platelet BioGenesis](https://millionrounds.com/company/platelet-biogenesis)
- [Medeor Therapeutics](https://millionrounds.com/company/medeor-therapeutics)
- [Kira Pharmaceuticals](https://millionrounds.com/company/kira-pharmaceuticals)
- [*D* dMed](https://millionrounds.com/company/dmed)
- [ReadCoor](https://millionrounds.com/company/readcoor)
- [ASLAN Pharmaceuticals](https://millionrounds.com/company/aslan-pharmaceuticals)

## Series C and later

12

- [Trevi Therapeutics](https://millionrounds.com/company/trevi-therapeutics)
- [Coherus Biosciences](https://millionrounds.com/company/coherus-biosciences)
- [Arcutis Biotherapeutics](https://millionrounds.com/company/arcutis-biotherapeutics)
- [IGM Biosciences](https://millionrounds.com/company/igm-biosciences)
- [Metacrine](https://millionrounds.com/company/metacrine)
- [RayzeBio](https://millionrounds.com/company/rayzebio)
- [Pulmocide](https://millionrounds.com/company/pulmocide)
- [*IN* Impel NeuroPharma](https://millionrounds.com/company/impel-neuropharma)
- [Ajax Therapeutics](https://millionrounds.com/company/ajax-therapeutics)
- [Genetron](https://millionrounds.com/company/genetron)
- [Cerebral Therapeutics](https://millionrounds.com/company/cerebral-therapeutics)
- [*SH* Swift Health Systems](https://millionrounds.com/company/swift-health-systems)

## Series A

10

- [Celcuity](https://millionrounds.com/company/celcuity)
- [*LB* Lepu Bio](https://millionrounds.com/company/lepu-bio)
- [Clasp Therapeutics](https://millionrounds.com/company/clasp-therapeutics)
- [Icosavax](https://millionrounds.com/company/icosavax)
- [Satsuma Pharmaceuticals](https://millionrounds.com/company/satsuma-pharmaceuticals)
- [Ablaze Pharmaceuticals](https://millionrounds.com/company/ablaze-pharmaceuticals)
- [*FT* Fortis Therapeutics](https://millionrounds.com/company/fortis-therapeutics)
- [Telum Therapeutics](https://millionrounds.com/company/telum-therapeutics)
- [Outpost Medicine](https://millionrounds.com/company/outpost-medicine)
- [EsoBiotec](https://millionrounds.com/company/esobiotec)

## Pre-seed and seed

4

- [Signadori Bio](https://millionrounds.com/company/signadori-bio)
- [OneChain Immunotherapeutics](https://millionrounds.com/company/onechain-immunotherapeutics)
- [Integra Therapeutics](https://millionrounds.com/company/integra-therapeutics)
- [Telomere Therapeutics](https://millionrounds.com/company/telomere-therapeutics)

## Segment by segment

### Stage not reported

23 startups · $4.0B raised

- [**Candid Therapeutics**](https://millionrounds.com/company/candid-therapeutics) Candid Therapeutics was a clinical-stage biotechnology company based in San Diego, California, founded in 2024. United States $875M
- [**Legend Biotech**](https://millionrounds.com/company/legend-biotech) Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology. United States $576M
- [**Immunic Therapeutics**](https://millionrounds.com/company/immunic-therapeutics) Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies. United States $400M
- [**Valneva**](https://millionrounds.com/company/valneva) Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases. France $310M
- [**Biohaven Pharmaceutical**](https://millionrounds.com/company/biohaven-pharmaceutical) Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases. United States $280M
- [**COMPASS Pathways**](https://millionrounds.com/company/compass-pathways) Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. United Kingdom $200M
- [**Tourmaline Bio**](https://millionrounds.com/company/tourmaline-bio) Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients. United States $173M
- [**Celladon**](https://millionrounds.com/company/celladon) Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure. United States $172M

### Series B

18 startups · $3.5B raised

- [**Terns Pharmaceuticals**](https://millionrounds.com/company/terns-pharmaceuticals) Terns Pharmaceuticals is a biopharmaceutical company that focuses on discovering therapies that will improve the global disease burden. United States $730M
- [*CT* **Cidara Therapeutics**](https://millionrounds.com/company/cidara-therapeutics) Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics. United States $463M
- [**Passage Bio**](https://millionrounds.com/company/passage-bio) Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases. United States $380M
- [**Expedition Therapeutics**](https://millionrounds.com/company/expedition-therapeutics) Expedition Therapeutics is a biotechnology company based in San Francisco, founded in 2024. United States $280M
- [**Surrozen**](https://millionrounds.com/company/surrozen) Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease. United States $258M
- [*BB* **Bolt Biotherapeutics**](https://millionrounds.com/company/bolt-biotherapeutics) Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. United States $189M
- [**Gracell Biotechnologies**](https://millionrounds.com/company/gracell-biotechnologies) Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer. China $185M
- [**Homology Medicines**](https://millionrounds.com/company/homology-medicines) Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases. United States $144M

### Series C and later

12 startups · $2.0B raised

- [**Trevi Therapeutics**](https://millionrounds.com/company/trevi-therapeutics) Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus. United States $386M
- [**Coherus Biosciences**](https://millionrounds.com/company/coherus-biosciences) Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases. United States $299M
- [**Arcutis Biotherapeutics**](https://millionrounds.com/company/arcutis-biotherapeutics) Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs. United States $245M
- [**IGM Biosciences**](https://millionrounds.com/company/igm-biosciences) IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer. United States $209M
- [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M
- [**RayzeBio**](https://millionrounds.com/company/rayzebio) RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer. United States $160M
- [**Pulmocide**](https://millionrounds.com/company/pulmocide) Pulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007. United Kingdom $110M
- [*IN* **Impel NeuroPharma**](https://millionrounds.com/company/impel-neuropharma) United States $107M

### Series A

10 startups · $1.7B raised

- [**Celcuity**](https://millionrounds.com/company/celcuity) Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients. United States $1.0B
- [*LB* **Lepu Bio**](https://millionrounds.com/company/lepu-bio) China $160M
- [**Clasp Therapeutics**](https://millionrounds.com/company/clasp-therapeutics) Clasp Therapeutics is a clinical-stage biotechnology company founded in 2020, focused on precision immuno-oncology. United States $150M
- [**Icosavax**](https://millionrounds.com/company/icosavax) Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs. United States $119M
- [**Satsuma Pharmaceuticals**](https://millionrounds.com/company/satsuma-pharmaceuticals) Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product. United States $92M
- [**Ablaze Pharmaceuticals**](https://millionrounds.com/company/ablaze-pharmaceuticals) Ablaze Pharmaceuticals is a clinical-stage biopharmaceutical company based in Shanghai, China, with an office in San Diego, California. China $75M
- [*FT* **Fortis Therapeutics**](https://millionrounds.com/company/fortis-therapeutics) United States $58M
- [**Telum Therapeutics**](https://millionrounds.com/company/telum-therapeutics) Telum Therapeutics is a biotechnology and drug-discovery company based in Noáin, Navarra, Spain, founded in 2019. Spain $25M

### Pre-seed and seed

4 startups · $26M raised

- [**Signadori Bio**](https://millionrounds.com/company/signadori-bio) Signadori Bio is the next-generation cellular immunotherapy for cancer cure. France $13M
- [**OneChain Immunotherapeutics**](https://millionrounds.com/company/onechain-immunotherapeutics) OneChain Immunotherapeutics is a clinical-stage biotechnology company based in Barcelona, specializing in CAR-T and other immunoth Spain $7.3M
- [**Integra Therapeutics**](https://millionrounds.com/company/integra-therapeutics) Integra Therapeutics is a biotechnology company based in Barcelona, Spain, founded in 2020 as a spin-off from Pompeu Fabra University. Spain $3.2M
- [**Telomere Therapeutics**](https://millionrounds.com/company/telomere-therapeutics) Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis - $2.3M

**How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Vivo Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

## More portfolio maps

[All portfolios](https://millionrounds.com/portfolio-maps)

[Sector portfolio **Vivo Capital's Pharma portfolio** 17 startups · $2.3B](https://millionrounds.com/portfolio-maps/vivo-capital-pharma-portfolio)[Portfolio map **Vivo Capital portfolio map** 98 startups · $17B](https://millionrounds.com/portfolio-maps/vivo-capital-portfolio-map)[Co-investors **Who invests with Vivo Capital** 73 co-investors](https://millionrounds.com/portfolio-maps/vivo-capital-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio)

## Raising from investors like Vivo Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

[Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)
